[go: up one dir, main page]

AU2002226049A1 - Engineered plasmids and their use for in situ production of genes - Google Patents

Engineered plasmids and their use for in situ production of genes

Info

Publication number
AU2002226049A1
AU2002226049A1 AU2002226049A AU2604902A AU2002226049A1 AU 2002226049 A1 AU2002226049 A1 AU 2002226049A1 AU 2002226049 A AU2002226049 A AU 2002226049A AU 2604902 A AU2604902 A AU 2604902A AU 2002226049 A1 AU2002226049 A1 AU 2002226049A1
Authority
AU
Australia
Prior art keywords
genes
situ production
engineered plasmids
plasmids
engineered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002226049A
Other languages
English (en)
Inventor
Shana Barbas-Frederickson
Katherine S. Bowdish
Ying-Chi Lin
John Mcwhirter
Mark Renshaw
Martha Wild
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexion Pharmaceuticals Inc
Original Assignee
Alexion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharmaceuticals Inc filed Critical Alexion Pharmaceuticals Inc
Publication of AU2002226049A1 publication Critical patent/AU2002226049A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AU2002226049A 2000-12-05 2001-12-05 Engineered plasmids and their use for in situ production of genes Abandoned AU2002226049A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25144000P 2000-12-05 2000-12-05
US60/251,440 2000-12-05
PCT/US2001/047452 WO2002046435A2 (fr) 2000-12-05 2001-12-05 Plasmides modifies utilises pour la production in situ de genes

Publications (1)

Publication Number Publication Date
AU2002226049A1 true AU2002226049A1 (en) 2002-06-18

Family

ID=22951980

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002226049A Abandoned AU2002226049A1 (en) 2000-12-05 2001-12-05 Engineered plasmids and their use for in situ production of genes

Country Status (3)

Country Link
US (2) US20030049731A1 (fr)
AU (1) AU2002226049A1 (fr)
WO (1) WO2002046435A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002218022A1 (en) * 2000-12-08 2002-06-18 Alexion Pharmaceuticals, Inc. Plasmid vectors
FR2924440B1 (fr) * 2007-12-04 2015-01-09 Pf Medicament Nouveau procede de generation et de criblage d'une banque d'anticorps

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4661450A (en) * 1983-05-03 1987-04-28 Molecular Genetics Research And Development Limited Partnership Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides
GB8926269D0 (en) * 1989-11-21 1990-01-10 Dynal As Plasmid
US5427930A (en) * 1990-01-26 1995-06-27 Abbott Laboratories Amplification of target nucleic acids using gap filling ligase chain reaction
ES2089038T3 (es) * 1990-01-26 1996-10-01 Abbott Lab Procedimiento mejorado para amplificar acidos nucleicos blanco aplicable para la reaccion en cadena de polimerasa y ligasa.
WO1994018219A1 (fr) * 1993-02-02 1994-08-18 The Scripps Research Institute Procedes de production de banques d'anticorps utilisant des chaines legeres d'immunoglobulines universelles ou aleatoires
NO301082B1 (no) * 1995-07-20 1997-09-08 Statens Inst For Folkehelse Fremgangsmåte ved overvåkning av resultatet i Gap-LCR, samt nukleinsyresekvens til bruk ved fremgangsmåten
US5854033A (en) * 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
JP3974941B2 (ja) * 1995-11-21 2007-09-12 イェール ユニバーシティ 単分子セグメントの増幅および検出
EP0910666B1 (fr) * 1996-05-02 2006-08-09 Applera Corporation Quantification des transcrits d'arn utilisant l'adn genomique comme competiteur d'amplification interne
EP0920509B1 (fr) * 1996-06-24 2004-07-28 ZLB Bioplasma AG Polypeptides capables de former des structures de liaison a l'ant igene avec une specificite pour les antigenes de rhesus d, adn les codant et procede pour leur preparation et leur utilisation
JP2002539799A (ja) * 1999-03-19 2002-11-26 ジェネティックス・インスチチュート・インコーポレーテッド プライマー結合ベクター伸長（ＰＡＶＥ）：５’−指向ｃＤＮＡクローニング法
US6610472B1 (en) * 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast

Also Published As

Publication number Publication date
US20030049731A1 (en) 2003-03-13
WO2002046435A3 (fr) 2003-06-12
US20090011471A1 (en) 2009-01-08
WO2002046435A2 (fr) 2002-06-13

Similar Documents

Publication Publication Date Title
GB2408735B (en) Thermally-stable polycrystalline diamond materials and compacts
AU2002302364A1 (en) Amphoteric sterols and the use thereof in the production of pH-sensitive liposomes
AU1939801A (en) In situ bioreactors and methods of use thereof
AU2001290825A1 (en) Controlled release formulations and methods for their production and use
AU2002337497A1 (en) Carbon material, production method and use thereof
AU2001288299A1 (en) Electrochromic materials, devices and process of making
AU2001290986A1 (en) Improved runner and method of manufacture
SG99955A1 (en) Artificial stone and formation therefor
AU2002213838A1 (en) Method of producing non-bovine chymosin and use thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001280179A1 (en) Production and use of octafluoropropane
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2001277111A1 (en) Nonwoven material and method of producing the same
AU2001264910A1 (en) Plasticizable mixture and method of using
AU2003217545A1 (en) Concrete construction material and method of use
AU2001277889A1 (en) Veneer-based product and method of manufacture
AU2001279537A1 (en) Method and arrangement for the production of crossed stacks
AU2001232707A1 (en) Surface tinting composition and method of use
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2002226049A1 (en) Engineered plasmids and their use for in situ production of genes
AU2001235283A1 (en) Polymer-based nanocomposite materials and methods of production thereof
AU4057101A (en) Method for production of a dressing material and dressing material
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001266189A1 (en) Materials and methods relating to gene delivery
AU2001264934A1 (en) Dna repair polypeptides and methods of use